S3 Guideline for Bladder Cancer Claim and Reality a critical Commentary from the Guideline Coordinators

被引:0
|
作者
Retz, M. [1 ]
Maisch, P. [1 ]
Gschwend, J. E. [1 ]
机构
[1] Tech Univ Munich, Urol Klin & Poliklin, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany
来源
UROLOGE | 2016年 / 55卷 / 09期
关键词
D O I
10.1007/s00120-016-0196-0
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1188 / 1191
页数:4
相关论文
共 50 条
  • [21] S3 guideline: endocrine therapy of primary breast cancer
    Jackisch, C.
    Blohmer, J. -U.
    GYNAKOLOGE, 2018, 51 (07): : 548 - 555
  • [22] Methodology and process of developing the S3 guideline for prostate cancer
    Nothacker, M.
    Roellig, C.
    Woeckel, A.
    Kopp, I.
    Ollenschlaeger, G.
    Weinbrenner, S.
    UROLOGE, 2010, 49 (02): : 173 - +
  • [23] S3 guideline: Hormone replacement therapy and cancer risk
    Ortmann, Olaf
    Emons, Guenter
    Tempfer, Clemens
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2020, 18 (SUPPL 1): : 20 - 25
  • [24] Clinical Implementation and Consequences of the S3 Guideline "Esophageal Cancer"
    Bartella, Isabel
    Bruns, Christiane J.
    Schroeder, Wolfgang
    ZENTRALBLATT FUR CHIRURGIE, 2018, 143 (06): : 561 - 564
  • [25] S3 Guideline Prevention and Early detection of Skin Cancer
    Follmann, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 36 - 36
  • [26] Updated S3 Guideline for Gastric Cancer now published
    Moehler, Markus
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (12): : 1515 - 1516
  • [29] S3 guideline hepatitis C addendum
    Sarrazin, C.
    Berg, T.
    Buggisch, P.
    Dollinger, M. M.
    Hinrichsen, H.
    Hofer, H.
    Hueppe, D.
    Manns, M. P.
    Mauss, S.
    Petersen, J.
    Simon, K. -G.
    van Thiel, I.
    Wedemeyer, H.
    Zeuzem, S.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2015, 53 (04): : 320 - 334
  • [30] New S3 Guideline on Multiple Myeloma
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (04) : 234 - 235